Endovascular Treatment of Extracranial Internal Carotid Artery Aneurysms

Apply

Endovascular Treatment of Extracranial Internal Carotid Artery Aneurysms

Journal Title: Postępy Nauk Medycznych - Year 2012, Vol 25, Issue 5

Abstract

&lt;b&gt;Introduction.&lt;/b&gt; The purpose of this article is to present endovascular treatment options for extradural ICA aneurysms and evaluate their usefulness based on treatment success rate and complications.&lt;br&gt;&lt;b&gt;Materials and methods.&lt;/b&gt; We have treated 52 patients with extradural aneurysms, both true and false aneurysms, of the internal carotid artery (ICA) since 1999. Our techniques involved: stenting with bare and covered stents, primary coiling, remodeling with stent or balloon, ICA trapping and parental artery occlusion. Each procedure was performed after successful Balloon Test Occlusion (BTO).&lt;br&gt;&lt;b&gt;Results. &lt;/b&gt;Endovascular treatment was successful in all cases. Two patients had a TIA one month after primary coiling and one patient had a major stroke after parental artery occlusion.&lt;br&gt;&lt;b&gt;Conclusions.&lt;/b&gt; Our experience with extradural carotid aneurysms management shows that endovascular treatment of those lesions is both safe and efficient and should be considered a primary treatment option. However, good results depend heavily on proper choice of endovascular equipment and technique.

Authors and Affiliations

Michał Przyszlak, Tomasz Jargiełło, Maciej Szajner, Małgorzata Szczebo-Trojanowska

Keywords

Aneurysm carotid endovascular treatment tętniak tętnica szyjna leczenie wewnątrznaczyniowe

An analysis of discrepancies between test results of the selected protein parameters and clonal bone marrow plasma cells in an assessment of treatment response in a group of patients with multiple myeloma (MM) prior to an autologous hematopoietic stem cell transplantation (AHSCT)

Introduction. Multiple myeloma (MM) is an incurable, B-cell malignancy. Modern diagnostics and disease monitoring include the assessment of serum and urine protein as well as bone marrow examination. The discrepancies of...

Występowanie niezgodności słabych antygenów zgodności tkankowej w allogenicznych przeszczepieniach komórek krwiotwórczych od zgodnego w układzie HLA rodzeństwa

Oznaczyliśmy allele jedenastu słabych antygenów zgodności tkankowej (mHAg) i zbadaliśmy występowanie ich immunogennych niezgodności pomiędzy dawcą i biorcą w 35 allogenicznych przeszczepieniach komórek krwiotwórczych od...

EP ID EP54444
DOI -
Views 96
Downloads 0